Invasive Pulmonary Aspergillosis after COVID-19 Pneumonia

4Citations
Citations of this article
20Readers
Mendeley users who have this article in their library.

Abstract

COVID-19 emerged in China in late 2019 and quickly spread worldwide. The severe immunomodulation and depletion of lymphocytes caused by the virus and its therapy led to an increase in the incidence of superinfections. COVID-19-associated pulmonary aspergillosis (CAPA) is a new entity with increasing incidence and high associated mortality. We present the case of a 68-year-old patient admitted to our ward after recovering from severe COVID-19 pneumonia. Due to worsening of her clinical condition, chest computed tomography was performed and a lung abscess was documented with the identification of Aspergillus niger. Despite therapy with voriconazole, the patient’s condition deteriorated, culminating in her death.

Cite

CITATION STYLE

APA

David, F., Morais, J. R., Beires, F., Greenfield, H., & Fernandes, G. L. (2022). Invasive Pulmonary Aspergillosis after COVID-19 Pneumonia. European Journal of Case Reports in Internal Medicine, 9(3). https://doi.org/10.12890/2022_003209

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free